You have 7 free searches left this month | for more free features.

Recombinant herpes zoster vaccine

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HSV-2 Trial in Lenexa (pPJV7630 with pPJV2012 administered by PMED)

Completed
  • HSV-2
  • pPJV7630 with pPJV2012 administered by PMED
  • Lenexa, Kansas
    CPC Phase I Unit
Nov 20, 2008

Activation of Alternative Cellular Energy Pathway in Therapy of

Completed
  • Herpes Simplex
  • Herpes Zoster
    • (no location specified)
    May 30, 2008

    Prostate Cancer Trial in Portland (GM-CSF gene transduced allogeneic vaccine GVAX)

    Unknown status
    • Prostate Cancer
    • GM-CSF gene transduced allogeneic vaccine GVAX
    • Portland, Oregon
      Providence Portland Medical Center
    Feb 23, 2009

    Prophylaxis for Herpes Simplex Trial in Worldwide (Herpes simplex candidate vaccine- adjuvanted GSK 208141, Placebo)

    Completed
    • Prophylaxis for Herpes Simplex
    • Herpes simplex candidate vaccine- adjuvanted GSK 208141
    • Placebo
    • La Jolla, California
    • +46 more
    Jun 16, 2008

    Pulmonary Embolism, Thromboembolism Trial in China (rt-PA)

    Completed
    • Pulmonary Embolism
    • Thromboembolism
    • Beijing, Beijing, China
    • +22 more
    Oct 28, 2008

    Tuberculosis Trial in London (Ag85B-ESAT6 fusion protein H1)

    Terminated
    • Tuberculosis
    • Ag85B-ESAT6 fusion protein H1
    • London, England, United Kingdom
      St George's Vaccine Institute
    Oct 31, 2008

    Herpes Labialis Trial (ME-609)

    Completed
    • Herpes Labialis
    • (no location specified)
    Aug 14, 2008

    HIV and Genital Herpes Among High-Risk Sex With Men in Lima,

    Completed
    • HIV Infections
    • +3 more
      • Seattle, Washington
        Rachael McClennen
      Aug 7, 2008

      Herpes Labialis Trial in Mt. Pleasant (ME-609, acyclovir in ME-609 vehicle, Vehicle)

      Completed
      • Herpes Labialis
      • Mt. Pleasant, South Carolina
        Coastal Caroline Research Center
      Aug 14, 2008

      HIV Trial in Worcester (HIV-1 DNA vaccine with protein vaccine boost)

      Unknown status
      • HIV Infections
      • HIV-1 DNA vaccine with protein vaccine boost
      • Worcester, Massachusetts
        University of Massachusetts School of Medicine
      Sep 25, 2008

      Herpes Labialis Trial (ME-609, Acyclovir in ME-609 vehicle (5% acyclovir))

      Completed
      • Herpes Labialis
      • ME-609
      • Acyclovir in ME-609 vehicle (5% acyclovir)
      • (no location specified)
      Aug 14, 2008

      Tumors, Anemia Trial (Darbepoetin alfa, rHuEPO)

      Completed
      • Neoplasms
      • Anemia
      • (no location specified)
      Sep 11, 2008

      HIV Trial in Baltimore (SCBaL/M9)

      Unknown status
      • HIV Infections
      • SCBaL/M9
      • Baltimore, Maryland
        Institute of Human Virology
      Sep 25, 2008

      Infarction, Middle Cerebral Artery, Middle Cerebral Artery Stroke, Stroke, Acute Trial in Germany (recombinant human

      Completed
      • Infarction, Middle Cerebral Artery
      • +2 more
      • recombinant human erythropoietin alfa
      • 0.9% NaCl
      • Braunschweig, Germany
      • +8 more
      Oct 21, 2008

      Pneumococcal Infections Trial in Suva (Pneumovax 23, Prevnar)

      Completed
      • Pneumococcal Infections
      • Pneumovax 23
      • Prevnar
      • Suva, Fiji
        Colonial War Memorial Hospital
      Oct 20, 2008

      Herpes Labialis Trial (ME-609, Vehicle)

      Completed
      • Herpes Labialis
      • (no location specified)
      Aug 14, 2008

      Administration of Prevenar for Post-Marketing Surveillance

      Completed
      • Pneumococcal Infections
      • Prevenar
      • Seoul, Korea, Republic of
        (unnamed)
      Sep 24, 2008

      Seasonal Allergic Rhinitis Trial in Vienna (Fluticasone propionate, Placebo)

      Completed
      • Seasonal Allergic Rhinitis
      • Fluticasone propionate
      • Placebo
      • Vienna, Austria
        Allergy Centre Vienna West
      Sep 25, 2008

      HIV, Influenza, Vaccination Trial in Johannesburg (MUTAGRIP)

      Completed
      • HIV
      • +3 more
      • MUTAGRIP
      • Johannesburg, Gauteng, South Africa
        Helen Joseph Hospital
      Oct 8, 2008

      Lymphoma, Non-Hodgkin Trial in Los Angeles (recombinant human interleukin 21 and rituximab)

      Completed
      • Lymphoma, Non-Hodgkin
      • recombinant human interleukin 21 and rituximab
      • Los Angeles, California
        University of California, Los Angeles
      Sep 4, 2008

      Prophylaxis Herpes Simplex Trial in Gent (Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant, Herpes

      Completed
      • Prophylaxis Herpes Simplex
      • Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant
      • Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
      • Gent, Belgium
        GSK Clinical Trials Call Center
      Jun 13, 2008

      GlaxoSmithKline Biologicals Hepatitis A Vaccine in Korean

      Completed
      • Hepatitis A
      • Hepatitis A
      • (no location specified)
      Oct 15, 2008

      Prophylactic Pneumococcal Diseases Trial in Gent (pneumococcal vaccine)

      Completed
      • Prophylactic Pneumococcal Diseases
      • pneumococcal vaccine
      • Gent, Belgium
        GSK Investigational Site
      Oct 9, 2008

      Prevention of Bacillus Anthracis (Anthrax) Infection Trial in London, Merthyr Tydfil (rPA vaccine containing alhydrogel)

      Completed
      • Prevention of Bacillus Anthracis (Anthrax) Infection
      • rPA vaccine containing alhydrogel
      • London, United Kingdom
      • +1 more
      Sep 12, 2008

      HIV Trial in United States (APL 400-047, Bupivacaine HCl)

      Completed
      • HIV Infections
      • APL 400-047
      • Bupivacaine hydrochloride
      • Birmingham, Alabama
      • +3 more
      Sep 26, 2008